Skip to main content
SpringerLink
Log in

Abiraterone/docetaxel/olaparib

Drug resistance, bone marrow inhibition and liver toxicity: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Yuan F, et al. Circulating tumor DNA genomic profiling reveals the complicated olaparib-resistance mechanism in prostate cancer salvage therapy: A case report. World Journal of Clinical Cases 10: 3461-3471, No. 11, 16 Apr 2022. Available from: URL: http://doi.org/10.12998/wjcc.v10.i11.3461

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abiraterone/docetaxel/olaparib. Reactions Weekly 1908, 16 (2022). https://doi.org/10.1007/s40278-022-15744-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-15744-6

Search

Navigation